Clinical Trial Update: Combine TACE and RFA Versus TACE Alone for HCC With PVTT [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adding radiofrequency ablation to transarterial chemoembolization versus TACE alone for hepatocellular carcinoma with portal vein tumor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Ming Zhao | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN